Assertio Holdings Acquired by Zydus Worldwide DMCC | Healthcare M&A Deal

Zydus Worldwide DMCC has agreed to acquire Assertio Holdings, a pharmaceuticals business in Delaware, for $166.4 million. Assertio Holdings is a healthcare-focused pharmaceuticals company with common stock listed under CUSIP 04546C304, and the planned Assertio Holdings acquisition would move the business into a going private acquisition structure. Zydus Worldwide DMCC acquisitions are being pursued through Zara Merger Sub Inc., a Delaware corporation, as part of healthcare M&A and strategic acquisition activity. The going private acquisition is priced at $23.50 per share, subject to applicable withholding taxes and without interest, and is expected to close after the tender offer process begins.